Stockscreener 앱 받기
4.48
0.00%
0.00
시간 외 거래:
4.32
-0.16
-3.57%
전일 마감가:
$4.48
열려 있는:
$4.46
하루 거래량:
3.67M
Relative Volume:
0.71
시가총액:
$1.85B
수익:
$4.78B
순이익/손실:
$-284.68M
주가수익비율:
-6.4928
EPS:
-0.69
순현금흐름:
$-184.84M
1주 성능:
+3.70%
1개월 성능:
+23.42%
6개월 성능:
+23.08%
1년 성능:
-5.88%
1일 변동 폭
$4.3901
$4.575
1주일 범위
$4.045
$4.70
52주 변동 폭
$1.50
$7.73
애질론 헬스 Stock (AGL) Company Profile
명칭
Agilon Health Inc
전화
562-256-3800
주소
6210 E HWY 290, AUSTIN
AGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
4.48 | 1.85B | 4.78B | -284.68M | -184.84M | -0.69 |
|
HCA
Hca Healthcare Inc
|
336.46 | 82.19B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.45 | 14.27B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
150.78 | 13.22B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
130.78 | 12.77B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
185.91 | 11.80B | 15.42B | 1.03B | 956.84M | 15.02 |
애질론 헬스 Stock (AGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-01-10 | 개시 | Needham | Hold |
| 2024-12-16 | 개시 | Macquarie | Neutral |
| 2024-12-11 | 개시 | Bernstein | Mkt Perform |
| 2024-11-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-04-22 | 개시 | Citigroup | Neutral |
| 2024-03-06 | 개시 | Barclays | Underweight |
| 2024-02-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-02-26 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-05 | 다운그레이드 | Truist | Buy → Hold |
| 2023-12-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-11-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-10-20 | 개시 | The Benchmark Company | Buy |
| 2023-06-13 | 개시 | Evercore ISI | In-line |
| 2022-12-09 | 개시 | Stifel | Buy |
| 2022-09-14 | 개시 | RBC Capital Mkts | Outperform |
| 2022-09-12 | 개시 | Goldman | Buy |
| 2022-09-07 | 재개 | Truist | Buy |
| 2022-06-24 | 개시 | BTIG Research | Neutral |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-10-20 | 개시 | Jefferies | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-05-11 | 개시 | William Blair | Outperform |
| 2021-05-10 | 개시 | BofA Securities | Buy |
| 2021-05-10 | 개시 | Deutsche Bank | Buy |
| 2021-05-10 | 개시 | Goldman | Buy |
| 2021-05-10 | 개시 | JP Morgan | Overweight |
| 2021-05-10 | 개시 | Truist | Buy |
| 2021-05-10 | 개시 | Wells Fargo | Overweight |
| 2021-05-10 | 개시 | Wolfe Research | Outperform |
모두보기
애질론 헬스 주식(AGL)의 최신 뉴스
Q1 2025 Earnings Alert: agilon health Sets Critical Investor Call Date - StockTitan
agilon health Sets Date to Report First Quarter 2025 Financial Results - Joplin Globe
11 Best Performing Stocks So Far In 2025 - Insider Monkey
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday - Benzinga
4 Analysts Have This To Say About Agilon Health - Benzinga
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Agilon Health CTO Venkatachaliah Girish reports $13,409 in stock withholding - Investing.com Australia
agilon health, inc.'s (NYSE:AGL) Shares Leap 26% Yet They're Still Not Telling The Full Story - Simply Wall St
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Pack - The Globe and Mail
Agilon Health Faces Transition Year With Adjusted Financial Estimates - Evrim Ağacı
Agilon Health chief markets officer Shaker Benjamin sells $16,779 in stock - Investing.com India
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals - Benzinga
Agilon Health’s SWOT analysis: stock faces headwinds amid value-based care push By Investing.com - Investing.com South Africa
Agilon Health’s SWOT analysis: stock faces headwinds amid value-based care push - Investing.com
Healthcare Providers & Services Stocks Q4 In Review: The Ensign Group (NASDAQ:ENSG) Vs Peers - The Globe and Mail
Agilon Health: Strategic Focus and Conservative Guidance Drive Buy Rating Amidst Modest Q4 Improvement - TipRanks
agilon health, inc. (NYSE:AGL) Given Average Rating of “Hold” by Brokerages - Defense World
5 Stocks Under $10 With Double-Digit Fair Value Upside Potential - Investing.com
Rhumbline Advisers Boosts Stock Position in agilon health, inc. (NYSE:AGL) - Defense World
Truist maintains Hold on Agilon Health, cuts revenue forecast By Investing.com - Investing.com Canada
Truist maintains Hold on Agilon Health, cuts revenue forecast - Investing.com
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Handelsbanken Fonder AB Has $142,000 Holdings in agilon health, inc. (NYSE:AGL) - Defense World
agilon health, inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 20, 2024 to Discuss Your RightsAGL - ACCESS Newswire
UPCOMING AGL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds agilon health, inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
agilon health (NYSE:AGL) Price Target Raised to $3.50 - MarketBeat
Analysts Set Expectations for agilon health Q2 Earnings - MarketBeat
Leerink Partnrs Expects Lower Earnings for agilon health - MarketBeat
agilon health (NYSE:AGL) Announces Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Leerink Partnrs Cuts Earnings Estimates for agilon health - Defense World
Needham & Company LLC Reaffirms Hold Rating for agilon health (NYSE:AGL) - MarketBeat
AGL LAWSUIT ALERT: Levi & Korsinsky Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
US$3.56That's What Analysts Think agilon health, inc. (NYSE:AGL) Is Worth After These Results - Yahoo Finance UK
agilon health, inc. (NYSE:AGL) Analysts Are Pretty Bullish On The Stock After Recent Results - Simply Wall St
Shareholders that lost money on agilon health, inc. (AGL) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
Agilon Health Faces Financial Challenges Amid Rising Costs and Enrollment Risks: Analyst Recommends Sell Rating - TipRanks
Shareholders of agilon health, inc. Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights – AGL - ACCESS Newswire
Stifel Nicolaus Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock - Defense World
agilon health, inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights – AGL - ACCESS Newswire
AGL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds agilon health, inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Agilon Health’s Earnings Call: Growth Amid Challenges - TipRanks
Lost Money on agilon health, inc. (AGL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on agilon health, inc. (AGL) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Agilon Health stock target raised to $4 by Benchmark - Investing.com
agilon health (NYSE:AGL) Shares Up 5.6% After Analyst Upgrade - MarketBeat
agilon health (NYSE:AGL) Shares Gap DownTime to Sell? - MarketBeat
agilon health Q1 EPS Forecast Decreased by William Blair - MarketBeat
Cautious Hold Rating on Agilon Health Amid Uncertainty and Cost Challenges - TipRanks
Stifel raises agilon health stock price target to $3 from $2 - Investing.com Australia
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Stifel raises agilon health stock price target to $3 from $2 By Investing.com - Investing.com South Africa
애질론 헬스 (AGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
1.35%
자본화:
|
볼륨(24시간):